Advertisement

Merck Canada announces its antiviral COVID-19 treatment will be manufactured in Ontario

Molnupiravir is still pending regulatory approval. Thermo Fisher Scientific in Whitby is one of three facilities that will manufacture the oral treatment for Canada and around the world. Marianne Dimain reports.